Skip to main content
logo
Aptevo Therapeutics Inc. (APVO)
NASDAQ: APVO · Real-Time Price · USD
4.390
+0.020 (0.46%)
At close: Jul 24, 2026, 4:00 PM EDT
4.420
+0.030 (0.68%)
After-hours: Jul 24, 2026, 7:34 PM EDT

Aptevo Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
----3.1112.29
Revenue Growth
-----74.67%185.26%
Gross Profit
----3.1112.29
Operating Income
-26.67-26.31-24.6-28.88-28.64-21.4
Net Income
-26.26-27.54-24.13-34.8216.05-56.91
Earnings Per Share
-79.52-87.27--870550.00--
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
14.5321.628.7116.922.6445.04
Total Debt
4.424.635.45.49.5416.72
Net Cash (Debt)
10.116.993.3211.5113.128.33
Net Cash Growth
-412.21%-71.17%-12.16%-53.76%125.46%
Net Cash Per Share
22.8553.85-575.35--

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-26.98-25.59-23.79-11.73-21.02-21.68
Capital Expenditures
-----0.03-0.71
Free Cash Flow
-26.98-25.59-23.79-11.73-21.05-22.39
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
----100.00%100.00%
Operating Margin
-----919.75%-174.10%
Pretax Margin
----257.77%-231.51%
Profit Margin
----483.01%-470.75%
FCF Margin
-----676.01%-182.17%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-160.84160.84160.84160.84160.84
PS Ratio
----4.803.00